Stock comparison
United Therapeutics
Waters
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
WAT
Waters
Market cap
$22.32B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | UTHR | WAT | Winner |
|---|---|---|---|
| Warren Buffett | 71B | 63C | UTHR |
| Benjamin Graham | 76B | 62C | UTHR |
| Philip Fisher | 76B | 60C | UTHR |
| Peter Lynch | 62C | 21F | UTHR |
| Joel Greenblatt | 46D | 48D | WAT |
| Charlie Munger | 64C | 65C | WAT |
| Terry Smith | 64C | 59C | UTHR |
Side-by-side metrics
| Metric | UTHR | WAT |
|---|---|---|
| Market cap | $24.13B | $22.32B |
| P/E (TTM) | 19.2x | 63.6x |
| EV/EBIT | 15.2x | 30.7x |
| ROIC (TTM) | 18.81% | 2.25% |
| Gross margin | 86.58% | 55.02% |
| Net margin | 40.61% | 11.91% |
| Revenue CAGR 5y | 17.22% | 3.24% |
| EPS CAGR 5y | 29.84% | -1.02% |
| Debt / Equity | - | 0.3x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- EPS CAGR 5y29.84%vs -1.02%+103%
- Debt / Equity-vs 0.3x+100%
- ROIC (TTM)18.81%vs 2.25%+88%
- Revenue CAGR 5y17.22%vs 3.24%+81%
WAT leads on
No clear edges - the other side wins or ties on every measured metric.
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.